entertainment -WSS

entertainment

author：leisure time 2025-10-02 01:08:49 - browse：1912

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Adidas to release second batch of Yeezy sneakers after breakup with Ye

leisure time

WSS

Doctors in states that ban abortion can still help patients

What AstraZeneca

BIO to announce reorganization, senior leaders expected to depart

Warren pushes Witty on UnitedHealth's control over physicians

American TikTok star stuck in Dubai for months following rental car altercation

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

entertainment

entertainment

The need-to-know this morning

Is it time to worry about Moderna?

focus

23andMe had bad news about my health. I wish a person had delivered it

Doctors increasingly discourage vaping amid mounting health concerns

Apple is now the first public company to be valued at $3 trillion

Poland's lawmakers approve a divisive law on Russian influence

Medical leaders decry Supreme Court decision on affirmative action

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Activists slam private health insurers over coverage restrictions

Russian and Belarusian players banned from a women's tennis tournament in Prague

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Doctors increasingly discourage vaping amid mounting health concerns

leisure time

Campaign finance charge dropped from case against Sam Bankman

Is it ever OK for doctors to lie to their patients?

Welsh Carson private equity firm escapes from FTC antitrust case

HCA says smaller share of spending going to labor

Doctors increasingly discourage vaping amid mounting health concerns

Many immigrants are left out of maternal health programs

hotspot

knowledge

leisure time

focus